Development of adverse sequelae in children born with subclinical congenital Toxoplasma infection
- PMID: 7432882
Development of adverse sequelae in children born with subclinical congenital Toxoplasma infection
Abstract
Most infants born with congenital Toxoplasma infection are asymptomatic in the newborn period, and therefore their infection is not recognized. We performed follow-up evaluations on 24 such children. The mean age of these children at least examination was 8.5 years. In group I (13 children), the diagnosis was made prospectively. In group II (11 children), no symptoms or signs were noted in the newborn period and the diagnosis was made only after the first sign developed. Eighty-five percent of the children in group I and all of the children in group II have developed chorioretinitis. In group I, three children (23%) have unilateral blindness; in group II, three children (27%) and five children (45%) have unilateral and bilateral blindness, respectively. One child (8%) in group I and two children (18%) in group II developed severe, permanent neurologic sequelae after they initially presented with eye disease. Two of the children in each group are now retarded (IQ score range, 36 to 62). Six of the children in group I who were tested sequentially have had lower IQ scores (mean change from 97 to 74) on repeat tests performed an average of 5.5 years later. Less severe neurologic, intellectual, and audiologic deficits were observed in other children in each group. Treatment of some children may have had a beneficial effect on their outcome.
Similar articles
-
Neurologic and developmental outcome in treated congenital toxoplasmosis.Pediatrics. 1995 Jan;95(1):11-20. Pediatrics. 1995. PMID: 7770286
-
Impact of visual impairment on measures of cognitive function for children with congenital toxoplasmosis: implications for compensatory intervention strategies.Pediatrics. 2006 Aug;118(2):e379-90. doi: 10.1542/peds.2005-1530. Epub 2006 Jul 24. Pediatrics. 2006. PMID: 16864640
-
Neonatal serologic screening and early treatment for congenital Toxoplasma gondii infection. The New England Regional Toxoplasma Working Group.N Engl J Med. 1994 Jun 30;330(26):1858-63. doi: 10.1056/NEJM199406303302604. N Engl J Med. 1994. PMID: 7818637
-
Chronic congenital infections of man.Yale J Biol Med. 1982 May-Aug;55(3-4):187-92. Yale J Biol Med. 1982. PMID: 6295002 Free PMC article. Review.
-
Neurologic manifestations of congenital infection.Clin Perinatol. 1981 Oct;8(3):445-65. Clin Perinatol. 1981. PMID: 7030574 Review. No abstract available.
Cited by
-
Otopathology in congenital toxoplasmosis.Otol Neurotol. 2013 Aug;34(6):1165-9. doi: 10.1097/MAO.0b013e31828297b6. Otol Neurotol. 2013. PMID: 23598697 Free PMC article.
-
Current recommendations and future prospects in the treatment of toxoplasmosis.Drugs. 1989 Dec;38(6):973-87. doi: 10.2165/00003495-198938060-00008. Drugs. 1989. PMID: 2693048 Review.
-
Maternal microchimeric cell trafficking and its biological consequences depend on the onset of inflammation at the feto-maternal interface.Semin Immunopathol. 2025 Jan 17;47(1):8. doi: 10.1007/s00281-025-01037-w. Semin Immunopathol. 2025. PMID: 39820729 Free PMC article. Review.
-
Onset of ocular complications in congenital toxoplasmosis associated with immunoglobulin M antibodies to Toxoplasma gondii.Eur J Clin Microbiol Infect Dis. 1990 Sep;9(9):671-4. doi: 10.1007/BF01964270. Eur J Clin Microbiol Infect Dis. 1990. PMID: 2226496
-
Analysis of Toxoplasma gondii surface antigen 2 gene (SAG2). Relevance of genotype I in clinical toxoplasmosis.Mol Biol Rep. 2010 Jul;37(6):2927-33. doi: 10.1007/s11033-009-9854-2. Epub 2009 Oct 20. Mol Biol Rep. 2010. PMID: 19842061